Journal of Critical Care · 2021 · 12 citations · 19 references
MedicineClinical SciencesInternal MedicineClinical EpidemiologyEpidemiologyPulmonologyAcute Lung InjuryAcute Respiratory Distress SyndromeAcute Respiratory Distress Syndrome VentilationMechanical VentilationRespiratory DiseaseRespiratory Failure Management28-Day MortalityCovid-19-associated Acute Respiratory Distress SyndromeLung Disease Severity GradingPulmonary Disease Severity GradingRespiratory Failure PrognosisRespiratory Status AssessmentSevere Acute Respiratory Syndrome
PURPOSE: We investigated changes in ARDS severity and associations with outcome in COVID-19 ARDS patients. METHODS: We compared outcomes in patients with ARDS classified as 'mild', 'moderate' or 'severe' at calendar day 1, and after reclassification at calendar day 2. The primary endpoint was 28-day mortality. We also identified which ventilatory parameters had an association with presence of severe ARDS at day 2. We repeated the analysis for reclassification at calendar day 4. RESULTS: Of 895 patients, 8.5%, 60.1% and 31.4% had mild, moderate and severe ARDS at day 1. These proportions were 13.5%, 72.6% and 13.9% at day 2. 28-day mortality was 25.3%, 31.3% and 32.0% in patients with mild, moderate and severe ARDS at day 1 (p = 0.537), compared to 28.6%, 29.2% and 44.3% in patients reclassified at day 2 (p = 0.005). No ventilatory parameter had an independent association with presence of severe ARDS at day 2. Findings were not different reclassifying at day 4. CONCLUSIONS: In this cohort of COVID-19 patients, ARDS severity and mortality between severity classes changed substantially over the first 4 days of ventilation. These findings are important, as reclassification could help identify target patients that may benefit from alternative approaches.
19
Acute Respiratory Distress Syndrome
Ards Definition Task Force · JAMA · 2012 · 8.8K citations
Prone Positioning in Severe Acute Respiratory Distress Syndrome
Claude Guérin, Jean Reignier, Jean‐Christophe Richard et al. · New England Journal of Medicine · 2013 · 4.1K citations · Full text
Neuromuscular Blockers in Early Acute Respiratory Distress Syndrome
Laurent Papazian, Jean-Marie Forel, Arnaud Gacouin et al. · New England Journal of Medicine · 2010 · 2.4K citations · Full text